Unichem Laboratories Q3FY17 results

Unichem Laboratories Ltd. Ltd. reported its results today for the quarter ended December 31, 2016.  The total sales for Q3FY17 came in at Rs 359.92 crore, representing a 2.2 per cent sequential decline and 16.4 per cent YoY increase.

The operating profit (EBIT) for the quarter amounted to Rs 33.97 crore and the EBIT margin stood at 9.44 per cent. 

The company reported PAT of Rs 26.1 crore which represents a sequential QoQ increase of 27.19 per cent and a YoY increase of 11.35 per cent.

The company's cumulative filings of ANDAs stood at 38, out of which 21 ANDAs are approved. Further, revenues from domestic formulations saw a 6 per cent QoQ growth at Rs 203.6 crore, as against Rs 191.5 crore.

Unichem Laboratories Ltd is an India-based pharmaceutical company.engaged in the manufacture of a range of formulations, which includes therapeutic areas, such as cardiac care, anti-diabetics, nero-psychiatry, gastroenterologicals, anti-infectives, dermatology and nutraceuticals, amongst others. The company also manufactures active pharmaceutical ingredients. Its products are in the area of cardiology, diabetology, psychiatry, neurology, anti-bacterials, and pain management, among others.